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Awareness of energy drink intake
guidelines and associated consumption
practices: a cross-sectional study
Amy Peacock1,5, Nicolas Droste2*, Amy Pennay3, Peter Miller2, Dan I. Lubman4 and Raimondo Bruno1
Abstract
Background: Despite concern regarding harms of energy drink (ED) consumption, no research has been conducted to
determine awareness and compliance with ED intake guidelines displayed on product packaging in Australia (a novel
approach internationally).
Methods: A convenience sample of 1922 people completed an online survey. Participants reported their knowledge of
maximum recommended daily ED intake according to Australian guidelines.
Results: Guideline awareness was reported by 38, 23 and 19 % of past year consumers, lifetime, and non-consumers,
respectively. Amongst past year consumers, ‘accurate estimators’ reported greater ED intake and were more likely to
exceed intake guidelines and consume alcohol mixed with ED (AmED). After controlling for demographics and frequency
of use, guideline awareness predicted increased likelihood of exceeding guidelines in ED sessions, but was not associated
with exceeding ED guidelines in AmED sessions.
Conclusions: Australia is considered to have the most stringent regulatory approach to EDs internationally. However,
advisory statements are not associated with greater awareness and compliance with intake guidelines. Failure to comply
with standards for efficacious product labelling, and absence of broader education regarding guidelines, needs to be
addressed.
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Background
Energy drinks (EDs) are beverages advertised as enhancing
energy, alertness and performance. EDs have increased in
popularity in the last decade: half of an Australian
population-based young adult sample reported monthly
or more frequent use [1], with research suggesting that
the average age of onset for ED use is 10 years [2]. Data
from Australian and US poison information call centres
and emergency departments show increasing numbers of
ED-related exposure cases in the last decade [3–6]. Con-
sumers report negative stimulant effects of ED consump-
tion, including headaches, heart palpitations, agitation,
and sleeping difficulties [7–9], with more serious side-
effects evident in clinical data, particularly after excessive
consumption or in the presence of an existing medical
condition [10–12]. Consequently, researchers and health
professionals have expressed concern that these beverages
may cause harm when consumed in excess [13].
The negative effects of EDs are attributed to the primary
psychoactive ingredient, caffeine, as the typical symptom
profile matches that evident following excessive caffeine
intake [14]. Australia and Canada have requirements that
ED product labelling must specify the caffeine content in
the beverage [15, 16]; the US and European Union only
require such labelling if classified as a ‘beverage’ or if con-
tent exceeds 150 mg/L, respectively [17, 18]. Australia and
Canada additionally require an intake advisory statement
(e.g., “Consume no more than [quantity (as cans, bottles
or mL)] per day”). In Australia, the maximum recom-
mended daily intake is 500 mL ED (160 mg caffeine) per
day (exceedance of this guideline hereafter referred to as
‘excess intake’). As of August 2008, Food Standard
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Australia Zealand required that this guideline be conveyed
to consumers via the advisory statement printed on the
beverage container. However, there are no legal require-
ments as to the wording, location, size, and visibility of
this statement, and this advisory statement has been de-
scribed as confusing, of low visibility, and often worded to
encourage, rather than discourage, excess consumption
[19, 20].
Health advisory statements are targeted at “informa-
tion-sensitive” consumers who are able and willing to at-
tend to, comprehend, recall, and act on the message.
However, attention is impacted by bottom-up factors
(e.g., characteristics of the advisory statement) as well as
top-down factors [e.g., motivations for use; 21]. Even if
the message is processed, consumers will engage in lay
epidemiology to justify their preferred consumption
practices, and will act upon existing beliefs, experiences
or attitudes which alter their interpretation of the health
message [21–23]. Prior research assessing advisory state-
ments for other products provide mixed support in
regards to awareness and compliance. The majority of
the population is well aware of the harmful effects of
smoking because of a range of evidence-based measures,
including clear front of pack labelling, with some evi-
dence of efficacy in promoting smoking cessation and
preventing smoking initiation [24, 25]. The impact of
health warning labels is dependent upon their location,
size and design, with poorer recall of obscure text-only
warnings which appear on the side or back of packaging
[24]. Indeed, alcohol labelling continues to achieve poor
levels of recall [26–28], similar to that observed for ob-
scure text-only tobacco labelling [24], due to less-than-
optimal size, positioning, and design of labelling. Better
recall of labelling has been associated with heavier alco-
hol consumption [26, 29], presumably due to greater ex-
posure over time to alcohol packaging.
Despite increasing concern regarding the potential harms
of excess ED consumption [13] and evidence for varying ef-
ficacy of labelling advisory statements, no research has been
conducted to date to determine consumer awareness of, or
behavioural compliance with, ED intake guidelines as speci-
fied via the labelling advisory statement. Given increasing
popularity of alcohol mixed with energy drink (AmED)
consumption and evidence of increased likelihood of excess
ED consumption when consuming AmED [30, 31], it is
crucial that any attempts to capture awareness and behav-
ioural compliance also takes into account consumption
practices when EDs are consumed independently and in
combination with alcohol. Consequently, the aims of the
present exploratory study were to assess:
1. Awareness of ED intake guideline (according to
product labelling) among an Australian community
sample;
2. Compliance with guidelines according to consumers’
awareness of guidelines;
3. Demographic profile and AmED consumption
practices of consumers according to guidelines
awareness; and
4. Whether awareness of guidelines is independently
associated with actual ED consumption (in ED and
AmED drinking sessions) after controlling for other
covariates for consumption, including frequency of
use.
Methods
Participants and procedure
A convenience sample of 2953 people aged 16 years or
older residing in New South Wales, Australia, completed
an online survey between December 2012 and February
2013. An online advertising campaign was adopted to
deliberately and non-randomly capture consumers of ED
in New South Wales, including advertising on social
media websites and internet forums, media reports, and
email snowballing amongst professional and university-
based networks. Participants were invited to complete
the survey regardless of their history of ED use. Partici-
pants provided informed consent and survey completion
took 15–30 min. After submitting their responses, par-
ticipants could redirect to a secure webpage and enter a
prize draw to win one of ten Apple iPads. Participant
Internet Protocol (IP) addresses were collected and
stored independently of survey responses to ensure each
participant was unique. Ethics approval was granted by
the Deakin University Human Ethics Advisory Group
(#2012-257).
Measures
Participants were informed throughout the survey that
an ED was defined as “any caffeinated drink which is ad-
vertised primarily as providing benefits to physical and
mental performance, endurance, concentration and/or
stamina”. This definition was accompanied by images of
common products in Australia, and quantification of a
standard ED unit (one 60 mL ED shot = 1 standard ED;
one 250 mL ED beverage = 1 standard ED; one 500 mL
ED beverage = 2 standard EDs). This quantification was
based on standard beverage packaging and composition
of products (80 mg of caffeine per 250 mL beverage, the
maximum concentration permissible under current
regulation).
In addition to items pertaining to demographics (age,
sex, currently employed, currently studying for a tertiary
qualification, and completed a tertiary qualification), par-
ticipants were asked “According to Australian guidelines,
what is the maximum recommended amount of stand-
ard EDs that should be consumed per day?”.
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Participants were also asked about their average daily
caffeine intake (mgs) by reporting typical daily intake of
caffeinated products (excluding EDs). The caffeine con-
tent of foods and beverages was based on the Australia
New Zealand Food Standards nutrient database [32] or
product packaging. Participants were also asked about
lifetime and past 12 month ED use and AmED use. Past
12 month consumers were asked about frequency of use
(‘less than monthly’, ‘2–4 times a month’, ‘2–3 times a
week’, and ‘four or more times a week’), and ED intake
in typical and maximum ED and AmED sessions in the
past 12 months. Alcohol intake estimates in typical and
maximum AmED sessions were also obtained from
those participants who reported using AmED. Based on
the Australian guidelines, the maximum recommended
daily ED intake was defined as two standard ED units
(2 x 250 mL ED) [15] and maximum alcohol intake
to reduce risk of alcohol-related injury was defined as
four standard drinks [33].
Availability of data and measures
The survey instrument and data can be made available
on request of the corresponding author.
Analyses
The inclusion rate following data cleaning was 65.1 % (n =
1922). Cases were removed if participants were not a NSW
resident or if there were missing data for items deemed crit-
ical to the research question (i.e., age, alcohol/ED consump-
tion intake and frequency, and guideline awareness) or
survey progress logic. Participants were grouped according
to ED consumer status: ‘past year consumer’ (used in the
past 12 months), ‘lifetime consumer’ (used in lifetime but
not in the last 12 months) and ‘non-consumer’ (never con-
sumed ED in their lifetime); and by awareness of guidelines:
‘accurate estimators’ (2 standard EDs), ‘under-estimators’ (1
standard ED), ‘over-estimators’ (≥3 standard EDs) and ‘un-
aware consumers’ (‘don’t know’). Binary variables were also
created for ED intake (‘within guidelines ≤2 ED’ versus ‘ex-
ceeding guidelines ≥3 ED’) and alcohol intake (‘within
guidelines ≤4 standard alcoholic drinks’ versus ‘≥5 standard
alcoholic drinks’).
Analyses were conducted in SPSS Statistics Version 21
(IBM, Somers, NY) unless otherwise indicated. Descriptive
statistics comprised percentages and 95 % confidence inter-
vals (95 % CI) for categorical outcomes and mean and
standard deviation for continuous outcomes (Aim 1). Odds
ratios were calculated to compare year ED consumers
based on guideline awareness for DE consumption, socio-
demographic and AmED consumption outcomes (Aim 2
and 3) using Comprehensive Meta-Analysis Version 2
(Biostat, Englewood, NJ).
In order to determine whether guideline awareness is in-
dependently associated with actual consumption (Aim 4),
three-step hierarchical binary logistic regressions were
conducted; the dependent variable was whether past year
ED consumers had exceeded ED intake guidelines in typ-
ical and maximum ED sessions. As awareness of ED
guidelines is intended to result in behavioural compliance
with guidelines, ED guideline awareness (‘under-estima-
tors/over-estimators/unaware consumers’ (hereafter re-
ferred to as ‘uninformed consumers’) versus ‘accurate
estimators’) was entered at Step 1. Age, sex, employment,
educational qualification and current studying status were
entered at Step 2 based on research showing that ED users
are generally male and younger; employment and educa-
tional attainment were also included in the model given
contradictory findings regarding their association with ED
consumption [8, 34, 35]. Frequency of ED use was entered
at Step 3 based on literature showing that level of expos-
ure to advisory statements impacts awareness and behav-
ioural compliance [22]. As a proxy for overall ED
exposure, a variable was created to reflect the highest fre-
quency of use for ED for each participant (i.e., selected
highest frequency of use for ED or AmED).
Four-step hierarchical binary logistic regressions were
conducted to determine predictors of excess intake in typ-
ical and maximum AmED sessions. Models were as out-
lined above, with the exception that the binary variable for
exceeding alcohol intake guideline (‘within guidelines: ≤4
standard alcoholic drinks’ versus ‘≥5 standard alcoholic
drinks’) in typical and maximum AmED session was in-
cluded in Step 4. Across all analyses, significance levels
were maintained at p < .05.
Results
Sample characteristics
The sample predominantly comprised male (58 %, 95 % CI
55–61) young adults (M = 24.4, SD = 6.7). Half the sample
had acquired a diploma or tertiary qualification (48 %, 95 %
CI 45–50), nearly four-fifths were currently studying for a
diploma or tertiary qualification (78 %, 95 % CI 77–81)
(60 %, 95 % CI 57–63) and approximately half were cur-
rently employed (48 %, 95 % CI 45–50). Of the total sam-
ple, 80 % (95 % CI 78–81; n = 1530) had consumed an ED
in their lifetime, and 59 % (95 % CI 57–61, n = 1130) had
consumed an ED in the past year.
Awareness of guidelines
Analysis of guideline awareness by ED consumer status
showed that approximately two-fifths (38 %) of past year
consumers accurately reported the maximum recom-
mended daily ED intake. Almost one-third (31 %) under-
estimated and over one-quarter (27 %) were unsure of
the guideline, respectively; only a minority (5 %) overes-
timated the recommended maximum daily intake
(Table 1). One-half of lifetime consumers (51 %) and
non-consumers (56 %) reported being unaware of the
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guideline, with around one-fifth (23 and 19 %, respect-
ively) correctly reporting the maximum recommended
daily ED intake.
ED Use according to guideline awareness
Comparison of ED intake (without alcohol) of past year
consumers on the basis of their guidelines awareness
showed that ‘under-estimators’, ‘over-estimators’ and ‘un-
aware consumers’ were less likely to report ED use every
two weeks or more frequent than ‘accurate estimators’
(39, 30, and 26 % versus 46 %, respectively). These three
groups were also less likely to report exceeding the guide-
lines on a monthly or more frequent basis as compared to
the ‘accurate estimators’ (11, 10, and 7 % versus 19 %, re-
spectively), although the comparison with the ‘over-esti-
mators’ group did not reach statistical significance.
‘Under-estimators’ and ‘unaware consumers’ reported
significantly lower ED intake in typical and maximum
ED sessions than ‘accurate estimators’, with significantly
fewer consumers in the former two groups exceeding
the ED intake guidelines in these sessions (Table 2).
Most notably, 43 % of ‘accurate estimators’ reported ex-
ceeding the guidelines in their maximum sessions while
almost half that percentage (27 and 24 %) reported this
behaviour in the ‘under-estimators’ and ‘unaware con-
sumers’ groups. Consumption patterns for ‘over-estima-
tors’ and ‘accurate estimators’ were generally similar
(although low statistical power should be noted here
given the small sample size).
Correlates of guideline awareness
The following analyses comprised comparison of ‘accurate
estimators’ versus the ‘uninformed consumers’ (referent
category; ‘under-estimators’, ‘over-estimators’ and ‘unaware
consumers’ combined); descriptive data for all four groups
are available in Additional file 1. Whilst the groups were
similar in regards to employment, education and typical
caffeine intake, ‘accurate estimators’ were significantly
younger and had greater odds of being female than ‘unin-
formed consumers’ (Table 3).
‘Accurate estimators’ had increased odds of reporting
past year AmED use relative to ‘uninformed consumers’.
Amongst those reporting past year AmED use, ‘accurate
estimators’ had almost two-fold increased odds of
reporting AmED use every two weeks or more frequent,
and they reported greater alcohol intake in typical and
maximum sessions as compared to ‘uninformed con-
sumers’. ED intake in AmED sessions was generally similar
across the groups, with approximately two-fifths (41 and
44 %) exceeding the guidelines in their typical AmED ses-
sion and three-fifths (55 and 60 %) exceeding the guide-
lines in their maximum AmED session for ‘uninformed
consumers’ and ‘accurate estimators’, respectively.
Guideline awareness as a predictor of exceeding the ED
guidelines
Exceeding ED guidelines in typical and maximum
independent ED sessions
Three-step hierarchical binary logistic regression analyses
showed that at Step 1, being an ‘accurate estimator’ was
significantly associated with exceeding guidelines in typ-
ical and maximum independent ED drinking sessions, ac-
counting for a small amount of variance (2 and 4 %,
respectively; Table 4). After controlling for demographics
(Step 2), there remained two-fold increased odds of ex-
ceeding the guidelines in both session types for ‘accurate
estimators’ and those who were male (controlling for age,
employment, and education), although these models still
accounted for only a small amount of variance in con-
sumption (5 and 9 %, respectively). Controlling for fre-
quency of consumption in these models (Step 3) reduced
the magnitude of effect of regulation estimation, with
there being a 50 % increase in odds of exceeding guide-
lines in both session types, and dropping to trend level ef-
fects for typical sessions. However, the inclusion of
frequency of ED consumption in these models substan-
tially increased the explained variance in consumption (17
and 33 % for typical and maximum ED sessions, respect-
ively). At Step 3, being male and consuming EDs more
than weekly was significantly associated with exceeding
the guidelines in typical ED drinking sessions, with a trend
towards ‘accurate estimators’ reporting a greater likelihood
of exceeding the guidelines.
Similar findings were evident for maximum ED ses-
sions; being an ‘accurate estimator’, male, and reporting
ED use every two weeks-to-weekly, or ED use more than
Table 1 Awareness of guidelines according to history of energy drink use
Awareness of guidelines Non-consumer Lifetime consumers Past year consumers
n = 387 % (95 % CI) n = 400 % (95 % CI) n = 1130 % (95 % CI)
Underestimated 23 (19–28) 24 (20–28) 31 (28–34)
Correct 19 (16–23) 23 (19–27) 38 (35–41)
Overestimated 2 (1–4) 3 (2–5) 5 (4–6)
Don’t know 56 (51–61) 51 (46–56) 27 (24–29)
Five participants who had not used ED in the past year did not identify whether they had consumed ED in their lifetime
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Table 2 Energy drink consumption (without alcohol) of past year consumers according to awareness of guidelines
A. accurate estimators B. under-estimators C. over-estimators D. unaware consumers B. vs A. (ref) OR C. vs A. (ref) OR D. vs A. (ref) OR
n = 398 n = 324 n = 50 n = 274 (95 % CI) (95 % CI) (95 % CI)
% ED use every two weeks + 46 (41–51) 39 (33–44) 30 (19–44) 26 (21–32) 0.75 (0.55–1.00),
p = .054
0.51 (0.27–0.96),
p = .037
0.42 (0.30–0.59),
p < .001
% Monthly or more frequent intake
in excess of guidelines
19 (15–23) 11 (8–15) 10 (4–21) 7 (5–11) 0.54 (0.35–0.83),
p = .005
0.48 (0.18–1.24),
p = .130
0.34 (0.20–0.57),
p < .001
Typical ED intake (M, SD) 1.6 (1.1) 1.4 (0.7) 1.7 (1.7) 1.4 (1.0) 0.74 (0.62–0.89),
p = .002
1.04 (0.83–1.31),
p = .724
0.82 (0.69–0.98),
p = .027
% Typical intake exceeds ED guidelines 8 (6–10) 11 (8–15) 6 (4–9) 9 (4–20) 0.49 (0.27–0.87),
p = .016
0.75 (0.26–2.21),
p = .605
0.54 (0.30–0.99),
p = .046
Maximum ED intake (M, SD) 2.9 (2.3) 2.3 (1.7) 2.9 (3.7) 2.1 (2.0) 0.87 (0.80–0.95),
p = .001
1.01 (0.90–1.12),
p = .921
0.81 (0.74–0.90),
p < .001
% Maximum intake exceeds ED
guidelines
43 (38–48) 27 (22–32) 36 (23–50) 24 (20–30) 0.50 (0.36–0.69),
p < .001
0.74 (0.39–1.41),
p = .364
0.44 (0.31–0.62),
p < .001
Twenty-five participants did not specify whether they had consumed EDs independently (n = 1105). Those values bolded indicate statistical significance (p < .050). Energy drink: energy drink; OR odds ratio, 95 % CI
95 % confidence interval
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weekly were independent predictors of exceeding the
guidelines in these sessions.
Exceeding ED guidelines in typical and maximum AmED
sessions
Four-step hierarchical binary logistic regression analyses
showed that at Step 1, being an ‘accurate estimator’ was
not significantly associated with exceeding ED intake
guidelines in typical and maximum AmED ED drinking
sessions. This absence of any relationship between guide-
line awareness and behaviour remained even after for con-
trolling for demographics (Step 2), frequency of ED use
(Step 3) and AmED use (Step 4).
Discussion
The present study demonstrated that approximately two-
fifths of past year consumers are aware of ED intake
guidelines. The literature on alcohol and tobacco labelling
suggest that vividness-enhancing characteristics (large-
print, simple message, graphic images) and location (iso-
lated and occupying a large area of the package) must be
maximised to garner attention [36, 37]. However, in
Australia there are no regulatory requirements for presen-
tation of ED advisory statements beyond the inclusion of a
text-based warning on packages. This is somewhat
surprising given the wealth of literature outlining basic
principles and guidelines for efficacious design of such
messages [38]. Given the current findings, there is
Table 3 Demographic profile and AmED consumption practices of past year ED consumers according to guideline awareness
N Total sample A. uninformed consumers
n = 703
B. accurate estimators
n = 427
B vs A (ref) OR (95 % CI)
Demographics and other drug use
Age (M, SD) 1130 24.4 (6.7) 25.0 (7.4) 23.5 (5.2) 1.49 (1.20–1.86), p < .001
% Male 1124 58 (55–61) 61 (57–65) 53 (48–58) 0.73 (0.57–0.93), p = .011
% Employed 1129 60 (57–63) 62 (58–65) 57 (53–62) 0.84 (0.66–1.07), p = .152
% Completed tertiary qualification 1123 48 (45–50) 49 (45–52) 46 (41–50) 0.89 (0.70–1.13), p = .342
% Currently studying tertiary qualification 1130 79 (77–81) 78 (75–81) 80 (76–84) 1.13 (0.84–1.52), p = .434
Daily caffeine intake (excluding ED; M, SD) 1136 205.5 (190.8) 162.5 (183.1) 200.5 (199.5) 1.06 (0.85–1.32), p = .582
Independent ED Use (past year) 1105 95 (93–96) 94 (92–96) 95 (93–97) 1.29 (0.74–2.26), p = .367
n = 1046 n = 648 n = 398
Amongst consumers:
% ED use every two weeks + 1046 36 (33–39) 33 (29–36) 46 (41–51) 1.73 (1.34–2.24), p < .001
Typical ED intake (M, SD) 976 1.5 (1.0) 1.4 (1.1) 1.6 (1.1) 1.47 (1.16–2.10), p = .001
% Typical intake exceeds ED guidelines 976 8 (6–10) 6 (5–8) 11 (8–15) 1.89 (1.19–3.01), p = .007
% Monthly + exceed ED guideline use 1041 13 (11–15) 10 (7–12) 19 (15–23) 2.23 (1.55–3.20), p < .001
Maximum ED intake (M, SD) 995 2.5 (2.2) 2.3 (2.0) 2.9 (2.3) 1.67 (1.32–2.10), p < .001
% Maximum intake exceeds ED guidelines 995 33 (30–36) 27 (23–30) 43 (38–48) 2.06 (1.57–2.70), p < .001
AmED Use (past year) 1130 64 (62–67) 61 (58–65) 69 (65–74) 1.43 (1.10–1.84), p = .006
n = 727 n = 431 n = 296
Amongst consumers:
% AmED use every 2 weeks + 722 19 (16–22) 15 (12–19) 25 (20–30) 1.78 (1.22–2.58), p = .002
Typical ED intake (M, SD) 713 3.0 (2.6) 3.1 (2.8) 3.0 (2.1) 1.05 (0.80–1.38), p = .721
% Typical ED intake exceeds guideline 713 42 (38–46) 41 (36–45) 44 (39–50) 1.16 (0.86–1.57), p = .336
Typical alcohol intake (M, SD) 719 5.9 (4.1) 5.5 (3.9) 6.5 (4.4) 1.52 (1.16–1.99), p = .002
% Typical alcohol intake exceeds guideline 719 54 (51–58) 51 (46–55) 59 (53–65) 1.41 (1.04–1.90), p = .026
Maximum ED intake (M, SD) 710 3.8 (3.0) 3.7 (3.0) 4.0 (2.9) 1.21 (0.92–1.59), p = .172
% Maximum ED intake exceeds guideline 710 57 (53–60) 55 (50–60) 60 (54–65) 1.21 (0.90–1.64), p = .211
Maximum alcohol intake (M, SD) 712 8.3 (6.7) 7.7 (6.7) 9.0 (6.6) 3.71 (0.9–15.02), p = .066
% Maximum alcohol intake exceeds guideline 712 64 (60–67) 59 (54–64) 71 (65–76) 1.69 (1.23–2.33), p = .001
Those values bolded indicate statistical significance (p < .050) and those italicised indicated a trend towards statistical significance (p < .100). ED energy drink,
AmED alcohol mixed with energy drink, M mean, SD standard deviation
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Table 4 Predictors of exceeding ED guidelines in typical and maximum ED sessions and AmED sessions
Exceed guidelines: typical ED
session (n = 962)
Exceed guidelines: maximum ED
session (n = 981)
Exceed guidelines: typical AmED
session (n = 704)
Exceed guidelines: maximum
AmED session (n = 694)
Model b p OR (95 % CI) b p OR (95 % CI) b p OR (95 % CI) b p OR (95 % CI)
Step 1 R2 = .017 R2 = .040 R2 = .002 R2 = .003
Accurate estimator 0.63 .008 1.88 (1.18–3.01) 0.74 <.001 2.10 (1.60–2.76) 0.15 .339 1.16 (0.86–1.57) 0.21 .183 1.23 (0.91–1.67)
Step 2 R2 = .045 R2 = .091 R2 = .029 R2 = .028
Accurate estimator 0.62 .011 1.86 (1.15–3.00) 0.69 <.001 1.99 (1.50–2.63) 0.10 .541 1.10 (0.81–1.50) 0.18 .270 1.19 (0.87–1.63)
Age 0.03 .158 1.03 (0.99–1.07) −0.01 .267 0.99 (0.96–1.01) −0.02 .219 0.98 (0.95–1.01) 0.00 .937 1.00 (0.97–1.03)
Male 0.72 .003 2.05 (1.27–3.34) 0.77 <.001 2.17 (1.64–2.86) 0.52 .001 1.69 (1.24–2.29) 0.40 .011 1.50 (1.10–2.04)
Employed −0.01 .957 1.01 (0.61–1.68) −0.05 .718 0.95 (0.71–1.27) 0.19 .247 1.21 (0.88–1.67) 0.32 .049 1.38 (1.00–1.91)
Completed tertiary −0.27 .334 0.76 (0.44–1.32) −0.17 .295 0.84 (0.61–1.16) −0.02 .912 0.98 (0.68–1.40) −0.19 .292 0.83 (0.58–1.18)
Studying tertiary 0.19 .569 1.21 (0.63–2.32) 0.18 .336 1.20 (0.83–1.75) 0.12 .580 1.12 (0.74–1.73) 0.21 .343 1.23 (0.80–1.87)
Step 3 R2 = .116 R2 = .329 R2 = .073 R2 = .089
Accurate estimator 0.41 .109 1.50 (0.91–2.26) 0.43 .007 1.54 (1.12–2.12) 0.01 .936 1.01 (0.74–1.39) 0.08 .640 1.08 (0.78–1.49)
Age 0.03 .192 1.03 (0.99–1.07) −0.02 .283 0.99 (0.96–1.01) −0.02 .320 0.98 (0.95–1.02) 0.01 .715 1.01 (0.98–1.04)
Male 0.62 .014 1.86 (1.13–3.05) 0.64 <.001 1.89 (1.38–2.59) 0.40 .013 1.49 (1.09–2.05) 0.24 .143 1.27 (0.92–1.76)
Employed −0.05 .852 0.95 (0.57–1.60) −0.21 .204 0.81 (0.58–1.12) 0.11 .517 1.12 (0.80–1.55) 0.24 .155 1.27 (0.91–1.77)
Completed tertiary −0.29 .314 0.75 (0.43–1.31) −0.21 .254 0.81 (0.57–1.16) 0.10 .956 1.01 (0.70–1.45) −0.16 .409 0.86 (0.59–1.24)
Studying tertiary 0.22 .517 1.25 (0.64–2.44) 0.21 .338 1.23 (0.81–1.88) 0.12 .615 1.12 (0.72–1.73) 0.19 .382 1.21 (0.79–1.87)
Frequency of use
Monthly or less (ref) - - - - - - - - - - - -
Every two weeks-weekly 0.15 .658 1.17 (0.59–2.29) 1.18 <.001 3.25 (2.29–4.62) 0.77 <.001 2.16 (1.49–3.13) 0.89 <.001 2.43 (1.67–3.54)
More than weekly 1.49 <.001 4.44 (2.56–7.73) 2.80 <.001 16.39 (10.58–25.40) 0.82 <.001 2.27 (1.47–3.51) 1.02 <.001 2.76 (1.75–4.35)
Step 4 - - R2 = .153 R2 = .223
Accurate estimator - - - - - - −0.06 .722 0.94 (0.68–1.31) −0.07 .695 0.93 (0.66–1.32)
Age - - - - - - −0.01 .598 0.99 (0.96–1.02) 0.02 .220 1.02 (0.99–1.06)
Male - - - - - - 0.20 .228 1.23 (0.88–1.71) 0.03 .855 1.03 (0.73–1.46)
Employed - - - - - - 0.10 .581 1.10 (0.78–1.55) 0.28 .127 1.32 (0.93–1.89)
Completed tertiary - - - - - - −0.04 .854 0.97 (0.66–1.41) −0.23 .243 0.79 (0.54–1.17)
Studying tertiary - - - - - - 0.05 .829 1.05 (0.67–1.64) 0.16 .492 1.18 (0.74–1.87)
Frequency of use - - - - - - - - - - - -
Monthly or less (ref) - - - - - - - - - - - -
Every two weeks-weekly - - - - - - 0.78 <.001 2.19 (1.50–3.19) 0.92 <.001 2.50 (1.68–3.73)
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Table 4 Predictors of exceeding ED guidelines in typical and maximum ED sessions and AmED sessions (Continued)
More than weekly - - - - - - 0.82 <.001 2.26 (1.45–3.52) 1.01 <.001 2.75 (1.70–4.46)
Exceed alcohol guidelines typical AmED sessions - - - - - - 1.12 <.001 3.05 (2.19–4.25) - - -
Exceed alcohol guidelines maximum AmED sessions - - - - - - - - - 1.53 <.001 4.63 (3.26–6.58)
This table presents the results of multivariate hierarchical binary logistic regression analyses. The dependent variable is whether the past year ED consumer reported exceeding ED maximum recommended daily intake
guidelines (≥3 standard 250 mL EDs) in typical and maximum ED and AmED drinking sessions in the preceding 12 months. Step 1: awareness of ED guidelines (‘uninformed consumer’ versus ‘accurate estimator’); Step
2: sex, age, employment, completed tertiary qualification, and studying for tertiary qualification; Step 3: frequency of ED use (‘fortnightly-weekly’ and ‘more than weekly’ versus ‘monthly or less); Step 4 (AmED models
only): exceeding alcohol intake guidelines (≥5 standard alcoholic drinks) in typical and maximum AmED sessions. Those values bolded indicate statistical significance (p < .050) and those italicised indicated a trend
towards statistical significance (p < .100). ED: energy drink; AmED: alcohol mixed with energy drink OR: odds ratio. 95 % CI: 95 % confidence interval
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sufficient evidence to suggest that current regulation
could be amended to more stringently regulate presenta-
tion of the advisory statement, maximising the opportun-
ity for consumers to become aware of guidelines.
However, awareness of advisory statements does not ne-
cessarily translate into behavioural compliance. Indeed,
this study demonstrated the inverse: that those who were
aware of the intake guidelines were more likely to exceed
the guidelines as compared to those who were inaccurate
or were unaware. Even after controlling for demographics
and frequency of use, guideline awareness predicted in-
creased likelihood of exceeding guidelines in typical and
maximum ED sessions (but not significantly so), and was
not associated with exceeding guidelines in typical and
maximum AmED sessions. These findings are not surpris-
ing given a wealth of literature showing a ‘boomerang ef-
fect’ of public health interventions, whereby effects
contrary to those intended are evident [39].
The simplest explanation for these findings is that regu-
lar ED consumers and those who consume multiple EDs
on a night out have more opportunity to observe the
guideline labels than those who use EDs less frequently
and in smaller amounts. Greater opportunity to read the
guidelines may therefore result in better knowledge of the
guidelines. Another explanation for these outcomes is that
‘accurate estimators’ might experience psychological react-
ance, whereby oppositional attitudes and behaviours are
created in response to perceived threats to personal choice
[39]. The results showed that ‘accurate estimators’ con-
sumed ED more frequently, and greater frequency of use
was shown to be a stronger independent predictor of ex-
ceeding the guidelines even after controlling for guideline
awareness. Greater familiarity with the product has been
linked with better recall but less attention to, and behav-
ioural compliance with, advisory statements [22]. Thus, it
may be that increased personal experience with the prod-
uct allows consumers to develop greater tolerance, as well
as independently judge the safety of the product, thus in-
creasing the chance of exceeding the guidelines. This form
of lay epidemiology helps to explain consumer justifica-
tion of contrarian health behaviours in the face of public
health messages, such as the use of illicit opioids and
binge alcohol consumption [23, 40] In this manner, ‘accur-
ate estimators’ who report exceeding guidelines are acting
as calculating consumers, whereby the risk of negative
health outcomes is weighed against personal and peer ex-
periences, the intended function of the drink, habitual use,
physiological dependence, motives for consumption, and
personal beliefs.
Given the cross-sectional nature of this study, we can-
not directly infer that awareness of guidelines influences
ED intake. However, the efficacy of these advisory state-
ments as a stand-alone approach to harm reduction for
EDs must be considered. Some researchers argue that an
advisory statement can be deemed successful if it in-
forms consumers of potential risks even if behavioural
compliance is not forthcoming, whilst others advocate
for measurable increases in behavioural compliance as
the indicator of efficacy (see Ringold, 2002; [39]). How-
ever, the current study shows that: 1) there is low aware-
ness of the guidelines amongst ED consumers, and 2) in
the main, awareness of guidelines does not necessarily
translate to healthier decisions in regards to ED intake.
The basic theoretical underpinnings of risk communica-
tion is that in order to make decisions about the risks
associated with a particular product, consumers need to
understand the type and likelihood of negative out-
comes, what factors alter susceptibility to these out-
comes, and how they might avoid harm [41]. That is,
people need to be informed of the severity and probabil-
ity of harm, and difficulty of avoiding harm [41]. Conse-
quently, it is not surprising that for most other
potentially hazardous products, advisory statements are
included as part of an integrated multi-faceted broader
campaign seeking to educate and inform consumers, in-
tegrated as part of school curriculum regarding alcohol
and other drug use and associated harms. Including only
an advisory statement means that there is no way to en-
sure consumers understand the warning, and determine
whether they perceive it as accurate. The current find-
ings speak to the importance of undertaking such an ap-
proach for ED consumption to ensure that the advisory
statements are placed in a broader context of knowledge
and understanding of adverse outcomes and harm re-
duction strategies.
This study was the first to systematically test awareness
of ED guidelines amongst a large sample of consumers and
non-consumers, providing critical insight into the need for
better policy responses in Australia and internationally. Dir-
ect comparison of ‘over-estimators’ with other guideline
awareness group was not possible due to small group size
resulting in low statistical power. It is important to note
that we did not explicitly assess whether participants were
aware of the guidelines from the product packaging. How-
ever, we can confidently assume that this knowledge was
derived from the advisory statement on ED packaging, as
we know of no other public health initiative in Australia to
promote these guidelines. It also should be noted that data
were self-reported and thus subject to potential bias, al-
though a web-based survey was used to allow independent
completion, and non-identifying information was collected
to assure anonymity. We also advocate for research which
assesses guideline awareness in the broader community; the
sample was not representative as participants were self-
selected as part of a strategic recruitment plan to target
AmED consumers. For example, 58 % of the current sam-
ple were male and median age was 24, whereas in NSW in
June 2013 the sex distribution was near-equal and median
Peacock et al. BMC Public Health  (2016) 16:6 Page 9 of 11
age was 38 years [42]. Critically, we believe the next step is
to undertake longitudinal research using consumers in the
community to explore how an individual consumer transi-
tions from lack of knowledge regarding the guidelines to a
state of awareness and subsequently to behavioural
compliance.
Conclusions
This study has shown that less than two-fifths of all ED
consumers in our Australian sample were aware of rec-
ommended maximum daily intake guidelines. Further,
the current findings suggest that awareness of guidelines
explains little of the variance in ED intake, and may ac-
tually be associated with greater likelihood of excess in-
take. These findings speak to the importance of ensuring
government regulation of ED advisory statements is in
accordance with best practice guidelines and that the la-
bels form part of an integrated multi-faceted broader
campaign seeking to educate and inform consumers, so
that they are informed of the severity and probability of
harm. Given that Australia is considered by industry to
have the tightest regulation of the ED market [43], these
findings also speak to the need for greater regulatory ac-
tion internationally to ensure that consumers are to
make informed decisions regarding their levels of ED
consumption.
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